Hepatitis C: Drugs That Work
Links shared publicly online about this topic.
- 513total visits
Hepatitis C: Drugs That Work
View full resource at newsmax.com
Tags: Liver, Liver Condition, Hepatitis, Hepatitis C, Hepatitis C Medication, Drug
Most Recently Shared on February 11, 2011 at 8:42 pm By:
Tina Banwart - HepatitisCNewDrugs
Currently reading Hepatitis C: Drugs That Work http://www.newsmax.com/FastFeatures/hepatitis-c-drugs-/2011/02/11/id/385790
HCV New Drug Research: TGIF-2012 EASL Round-Up
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: TGIF-2012 EASL Round-Up” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on April 20, 2012 at 5:48 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
TGIF-EASL Round-Up http://t.co/r1wj3gXM
HCV New Drug Research: EASL-Final Phase 2a Study Results For Miravirsen Showing Dose-dependent, Prolonged Antiviral Activity In Hepatitis C Patients
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: EASL-Final Phase 2a Study Results For Miravirsen Showing Dose-dependent, Prolonged Antiviral Activity In Hepatitis C Patients” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on April 19, 2012 at 11:23 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
EASL-Final Phase 2a Study Results For Miravirsen Showing Dose-dependent, Prolonged Antiviral… http://t.co/PqhgqDKH
HCV New Drug Research: EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the Treatment of Hepatitis C-ABT-450/r, plus ABT-333 and ribavirin
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the Treatment of Hepatitis C-ABT-450/r, plus ABT-333 and ribavirin” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on April 19, 2012 at 4:12 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the… http://t.co/es8fhWgM
HCV New Drug Research: EASL-BI 201335 and BI 207127-Viral cure achieved without interferon in up to 82% of hepatitis C patients (GT-1a & -1b*)
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: EASL-BI 201335 and BI 207127-Viral cure achieved without interferon in up to 82% of hepatitis C patients (GT-1a & -1b*)” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on April 19, 2012 at 4:12 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
EASL-BI 201335 and BI 207127-Viral cure achieved without interferon in up to 82% of hepatitis… http://t.co/p3KdpuhG
HCV New Drug Research: Idenix Pharmaceuticals Provides Update on Hepatitis C Clinical Development Programs
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Idenix Pharmaceuticals Provides Update on Hepatitis C Clinical Development Programs” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on April 19, 2012 at 3:11 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Idenix Pharmaceuticals Provides Update on Hepatitis C Clinical Development Programs http://t.co/DLrmPyFm
HCV New Drug Research: EASL:Hepatitis C-NEW DATA SUGGESTS INTERFERON-FREE THERAPY AROUND THE CORNER
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: EASL:Hepatitis C-NEW DATA SUGGESTS INTERFERON-FREE THERAPY AROUND THE CORNER” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on April 19, 2012 at 3:10 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
EASL:Hepatitis C-NEW DATA SUGGESTS INTERFERON-FREE THERAPY AROUND THE CORNER http://t.co/4I9kPBDl
Abbott Drugs Suppress Hepatitis C Virus in Studies - WSJ.com
online.wsj.com — “Experimental drugs from Abbott Laboratories suppressed the hepatitis C virus in most patients in two small, midstage studies.” View full resource at online.wsj.com
Most Recently Shared on April 4, 2012 at 4:28 pm By:
Abbott Drugs Suppress Hepatitis C Virus in Studies http://t.co/3XgYph1d
Abbott hepatitis drug 93% effective in small study - chicagotribune.com
chicagotribune.com — “A combination of experimental oral hepatitis C treatments being developed by Abbott Laboratories led to cure rates of more than 90 percent in previously untreated patients, according to data from a small mid-stage study.” View full resource at chicagotribune.com
Most Recently Shared on April 4, 2012 at 2:57 pm By:
John Carroll Health Communicator
Abbott is wowing the crowd with hep C data. from Reuters: http://t.co/6NZkH69v
10 Drug-free Remedies to Relieve Pain Now - iVillage
ivillage.com — “Setting up work chairs and home furniture, such as recliners, so you’re leaning back just a little bit -- instead of sitting ramrod straight or slouched forward -- can reduce your neck, shoulder, back and hip pain by 30 percent or more, UCLA res” View full resource at ivillage.com
Most Recently Shared on March 28, 2012 at 5:34 pm By:
Women In Pain Health Organization
10 Drug-Free Ways to Soothe Pain... http://t.co/cGQQmJv6
HCV New Drug Research: Victrelis (boceprevir)-B.C. expands PharmaCare coverage for Hepatitis C
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Victrelis (boceprevir)-B.C. expands PharmaCare coverage for Hepatitis C” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on March 26, 2012 at 9:11 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
B.C. expands PharmaCare coverage for Hepatitis C http://t.co/PRrvyT5U
HCV New Drug Research: Australia: Side-effect fears stall hepatitis C drugs
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Australia: Side-effect fears stall hepatitis C drugs” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on March 26, 2012 at 1:33 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Australia: Side-effect fears stall hepatitis C drugs http://t.co/K7sQyDbV
HCV New Drug Research: Hepatitis C Weekend Reading - Practical issues associated with boceprevir and telaprevir-based triple therapy
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Hepatitis C Weekend Reading - Practical issues associated with boceprevir and telaprevir-based triple therapy” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on March 24, 2012 at 2:26 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
#Hepatitis C Weekend Reading-Practical issues assoc w-boceprevir and telaprevir-based triple therapy http://t.co/Yg2E7lBz
HCV New Drug Research: Hepatitis C Weekend Reading - Practical issues associated with boceprevir and telaprevir-based triple therapy
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Hepatitis C Weekend Reading - Practical issues associated with boceprevir and telaprevir-based triple therapy” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on March 24, 2012 at 3:37 am By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Hepatitis C Weekend Reading - Practical issues associated with boceprevir and telaprevir… http://t.co/amVQELem
HCV New Drug Research: Video- Featuring Hepatitis C Advocate Shari Foster
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Video- Featuring Hepatitis C Advocate Shari Foster” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on March 23, 2012 at 1:41 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Video- Featuring Hepatitis C Advocate Shari Foster http://t.co/tKQ7i7di
Inhibiting Hepatitis C Virus:Discovery Provides Blueprint For New Drugs
medicalnewstoday.com — “Chemists at the University of California, San Diego have produced the first high resolution structure of a molecule that when attached to the genetic material of the hepatitis C virus prevents it” View full resource at medicalnewstoday.com
Most Recently Shared on March 21, 2012 at 8:05 am By:
Inhibiting Hepatitis C Virus:Discovery Provides Blueprint For New Drugs http://t.co/lXjquqaF #liver #hepatitis
Advertisement
